Sartorius AG

Sartorius, based in Göttingen, supplies the equipment and single-use components that pharmaceutical and biotech companies use to develop and manufacture medicines, especially biologics. It rode a pandemic-era boom, then a sharp destocking hangover, but the long-term growth of biological drugs underpins its prospects. Sartorius pays only a small dividend, choosing to reinvest heavily in capacity and research, so the yield is minimal despite a long record of paying. This is a quality growth stock in life-science tools, held for its long-term potential rather than for income.